Gaifa Lai

Person

Edison, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,829,036
- Issue date Sep 9, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,691,833
- Issue date Apr 8, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,691,831
- Issue date Apr 8, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,964,646
- Issue date Jun 21, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,763,609
- Issue date Jul 27, 2010
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Patent number 7,691,856
- Issue date Apr 6, 2010
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
- Patent number 7,671,212
- Issue date Mar 2, 2010
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,132,445
- Issue date Nov 7, 2006
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120276118
- Publication date Nov 1, 2012
- Pharmacopeia Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231017
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- ZHAONING ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231018
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...
- Publication number 20110213029
- Publication date Sep 1, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...
- Publication number 20090306079
- Publication date Dec 10, 2009
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS
- Publication number 20090281075
- Publication date Nov 12, 2009
- PHARMACOPEIA, INC.
- Andrew L. Roughton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20080200445
- Publication date Aug 21, 2008
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...
- Publication number 20080045489
- Publication date Feb 21, 2008
- Jianhua Chao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Publication number 20070264230
- Publication date Nov 15, 2007
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20070021494
- Publication date Jan 25, 2007
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
- Publication number 20060025453
- Publication date Feb 2, 2006
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...
- Publication number 20040186142
- Publication date Sep 23, 2004
- Schering Corporation Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040147559
- Publication date Jul 29, 2004
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Heterocyclic aspartyl protease inhibitors

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Patents Applicationslast 30 patents

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...

ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS

Heterocyclic aspartyl protease inhibitors

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...